Comparison of three risk assessment models for thromboembolism in multiple myeloma patients receiving immunomodulators: a Brazilian historical cohort-Reference-Cited by-同舟云学术

Comparison of three risk assessment models for thromboembolism in multiple myeloma patients receiving immunomodulators: a Brazilian historical cohort

Published:2023-05-03 Issue:1 Volume:56 Page:147-155
ISSN:1573-742X
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

da Costa Iwyson Henrique Fernandes^ORCID,de Pádua Cristiane Aparecida Menezes,de Miranda Drummond Paula Lana,Silveira Lívia Pena,Malta Jéssica Soares,dos Santos Roberta Márcia Marques,Reis Adriano Max Moreira

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

https://link.springer.com/content/pdf/10.1007/s11239-023-02817-7.pdf

Reference31 articles.

1. Malta JS, Silveira LP, de Drummond PLM, Costa NL, dos Santos RMM, Reis IA et al (2021) Validity and reliability of the QLQ-MY20 module for assessing the health-related quality of life in Brazilians with multiple myeloma. Curr Med Res Opin. 37(7):1163–1169

2. Fotiou D, Gavriatopoulou M, Terpos E (2020) Multiple myeloma and thrombosis: Prophylaxis and risk prediction tools. Cancers (Basel). 12(1):191

3. Baker HA, Brown AR, Mahnken JD, Shireman TI, Webb CE, Lipe BC (2019) Application of risk factors for venous thromboembolism in patients with multiple myeloma starting chemotherapy, a real-world evaluation. Cancer Med 8(1):455–462

4. Talamo GP, Ibrahim S, Claxton D, Tricot GJ, Fink LM, Zangari M (2009) Hypercoagulable states in patients with multiple myeloma can affect the thalidomide-associated venous thromboembolism. Blood Coagul Fibrinolysis 20(5):337–339

5. Palmaro A, Rougé-Bugat ME, Gauthier M, Despas F, Moulis G, Lapeyre-Mestre M (2017) Real-life practices for preventing venous thromboembolism in multiple myeloma patients: a cohort study from the French health insurance database. Pharmacoepidemiol Drug Saf 26(5):578–586

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Risk of Venous Thromboembolism and Ischemic Stroke Stratified by VTE Risk Following Multiple Myeloma: A Korean Population-Based Cohort Study;Journal of Clinical Medicine;2024-05-11

2. Validation of the IMPEDE VTE score for prediction of venous thromboembolism in Chinese patients with multiple myeloma: A single-center retrospective cohort study;Thrombosis Research;2024-04

3. Multiple Myeloma Drug Therapy: Considerations on Effectiveness and Safety;Interdisciplinary Cancer Research;2024